HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Pierre Raufman Selected Research

Bethanechol (Duvoid)

2/2018Genetic loss of the muscarinic M3 receptor markedly alters bile formation and cholestatic liver injury in mice.
4/2013Cholinergic muscarinic receptor activation augments murine intestinal epithelial cell proliferation and tumorigenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Pierre Raufman Research Topics

Disease

37Colonic Neoplasms (Colon Cancer)
01/2022 - 10/2002
28Neoplasms (Cancer)
01/2022 - 08/2003
7Carcinogenesis
01/2022 - 11/2011
7Fibrosis (Cirrhosis)
12/2019 - 06/2010
6Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 10/2005
4Neoplasm Metastasis (Metastasis)
01/2022 - 05/2011
4Diarrhea
02/2019 - 11/2016
3Infections
01/2022 - 04/2005
3Liver Diseases (Liver Disease)
01/2021 - 07/2005
2Adenocarcinoma
01/2022 - 04/2013
2Inflammation (Inflammations)
01/2022 - 01/2016
2Sclerosing Cholangitis
12/2019 - 02/2018
2Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
02/2019 - 05/2018
2Adenoma (Adenomas)
09/2011 - 03/2011
2Wounds and Injuries (Trauma)
05/2011 - 07/2007
1Disease Progression
01/2022
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Liver Neoplasms (Liver Cancer)
01/2022
1Iron Deficiencies
01/2022
1Cholestasis
01/2020
1Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
12/2019
1Acute Liver Failure (Fulminant Hepatic Failure)
12/2018
1Kidney Diseases (Kidney Disease)
01/2018
1End Stage Liver Disease
01/2018
1Sarcopenia
01/2018

Drug/Important Bio-Agent (IBA)

26Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA
01/2022 - 10/2002
20Bile Acids and Salts (Bile Acids)IBA
01/2022 - 10/2002
13Muscarinic M3 ReceptorIBA
01/2021 - 10/2002
11Acetylcholine (Acetylcholine Chloride)FDA Link
01/2022 - 04/2005
8Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2009
8Epidermal Growth Factor (EGF)IBA
01/2017 - 04/2005
7ErbB Receptors (EGF Receptor)IBA
10/2015 - 10/2003
6LigandsIBA
03/2019 - 10/2003
6AzoxymethaneIBA
05/2018 - 05/2008
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 04/2005
5Matrix Metalloproteinases (MMPs)IBA
01/2021 - 04/2009
5Messenger RNA (mRNA)IBA
03/2019 - 04/2009
4CateninsIBA
01/2022 - 09/2011
4Cholinergic Agents (Cholinergics)IBA
03/2019 - 10/2003
4Taurodeoxycholic AcidIBA
11/2011 - 04/2007
3p38 Mitogen-Activated Protein KinasesIBA
01/2022 - 01/2017
3RNA (Ribonucleic Acid)IBA
01/2022 - 01/2022
3Biological ProductsIBA
12/2021 - 04/2014
3Biomarkers (Surrogate Marker)IBA
12/2019 - 01/2018
3Phosphotransferases (Kinase)IBA
03/2019 - 10/2015
3EnzymesIBA
11/2013 - 04/2007
3AtropineFDA LinkGeneric
11/2013 - 09/2008
2CarcinogensIBA
01/2022 - 10/2015
2MicroRNAs (MicroRNA)IBA
01/2022 - 10/2015
2Pharmaceutical PreparationsIBA
01/2020 - 04/2005
2Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
03/2019 - 05/2008
2Mitogen-Activated Protein KinasesIBA
03/2019 - 01/2017
2AcidsIBA
02/2019 - 02/2002
2Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
02/2019 - 05/2018
2Bethanechol (Duvoid)FDA LinkGeneric
02/2018 - 04/2013
2Iothalamic Acid (Iotalamic Acid)FDA Link
01/2018 - 01/2018
2Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2016 - 04/2013
2Dextran SulfateIBA
10/2015 - 05/2013
2CollagenIBA
09/2015 - 07/2013
2Small Interfering RNA (siRNA)IBA
11/2013 - 01/2012
2Choline O-Acetyltransferase (Choline Acetyltransferase)IBA
11/2013 - 09/2008
2Conditioned Culture MediaIBA
11/2013 - 04/2009
2Scopolamine (Hyoscine)FDA Link
09/2011 - 06/2010
2Heparin-binding EGF-like Growth Factor (HB-EGF)IBA
04/2009 - 04/2007
2Matrix Metalloproteinase InhibitorsIBA
04/2009 - 04/2007
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2009 - 05/2008
2Cholinergic AgonistsIBA
10/2005 - 10/2003
1AgarIBA
01/2022
1ErythropoietinFDA Link
01/2022
1IronIBA
01/2022
1Phenobarbital (Luminal)FDA Link
01/2022
1Hepatocyte Nuclear Factor 4IBA
01/2022
1Transcription Factors (Transcription Factor)IBA
01/2022
1Muscarinic M1 ReceptorIBA
01/2022
1Constitutive Androstane ReceptorIBA
01/2022
1Rho Guanine Nucleotide Exchange FactorsIBA
01/2021
1Member 11 Subfamily B ATP Binding Cassette TransporterIBA
01/2020
1Metformin (Glucophage)FDA LinkGeneric
01/2020
1TamoxifenFDA LinkGeneric
01/2020
1Protein Kinase CIBA
03/2019
1Protein Kinases (Protein Kinase)IBA
03/2019
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
03/2019
1Hormones (Hormone)IBA
02/2019
123-seleno-25-homotaurocholic acidIBA
02/2019
1ElementsIBA
01/2019
1Matrix Metalloproteinase 7 (Matrilysin)IBA
01/2019
1Collagenases (Collagenase)FDA Link
01/2019
1Gastrointestinal Hormones (Hormones, Gastrointestinal)IBA
11/2018
1Dextrans (Dextran)FDA Link
05/2018
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
05/2018
13,5- diethoxycarbonyl- 1,4- dihydrocollidineIBA
02/2018
1S-AdenosylhomocysteineIBA
01/2018
1Glucuronic Acid (Glucuronate)IBA
01/2018
1Cystatin CIBA
01/2018
1Aconitic Acid (Aconitate)IBA
01/2018
1prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA
01/2018

Therapy/Procedure

7Therapeutics
01/2021 - 07/2005
2Drug Therapy (Chemotherapy)
01/2018 - 02/2009
1Immunotherapy
01/2018
1Transplantation
01/2018